EP2841445

2,2-Díflúorprópíónamíð afleiður af bardoxólón metýl, fjölbrigðaform og aðferðir við notkun þeirra

  • Status:
    EP einkaleyfi í gildi á Íslandi
  • EP appl. date:
    24.4.2013
  • EP published:
    14.6.2017
  • EP application number:
    13720708.0
  • Max expiry date:
    23.4.2033
  • Expiry date:
    23.4.2026
  • Next due date:
    30.4.2026
  • Title:
    2.2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE METHYL, POLYMORPHIC FORMS AND METHODS OF USE THEREOF

Timeline

Today
24.4.2013EP application
14.6.2017EP Publication
14.7.2017Translation submitted
15.8.2017Registration published
23.4.2026Expires

Owner

  • Name:
    Reata Pharmaceuticals Holdings, LLC
  • Address:
    5320 Legacy Drive, Plano, Texas 75024, US

Inventor

  • Name:
    ANDERSON, Eric
  • Address:
    Southlake, TX, US
  • Name:
    DECKER, Andrea
  • Address:
    Basel, CH
  • Name:
    LIU, Xiaofeng
  • Address:
    Coppell, TX, US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    201261687669 P
  • Date:
    27.4.2012
  • Country:
    US
  • Number:
    201361775288 P
  • Date:
    8.3.2013
  • Country:
    US
  • Number:
    201361780444 P
  • Date:
    13.3.2013
  • Country:
    US

Supplementary protection

Classification

  • Categories:
    C07J 63/00, A61K 31/565, A61P 29/00

Annual fees

Number

Paid

Expires

Payer

Number: 6

Paid: 9.4.2018

Expires: 23.4.2019

Payer: Árnason Faktor

Number: 7

Paid: 26.3.2019

Expires: 23.4.2020

Payer: Árnason Faktor

Number: 8

Paid: 7.4.2020

Expires: 23.4.2021

Payer: Árnason Faktor ehf.

Number: 9

Paid: 8.4.2021

Expires: 23.4.2022

Payer: Árnason Faktor ehf.

Number: 10

Paid: 5.4.2022

Expires: 23.4.2023

Payer: Árnason Faktor ehf.

Number: 11

Paid: 12.4.2023

Expires: 23.4.2024

Payer: Árnason Faktor ehf.

Number: 12

Paid: 10.4.2024

Expires: 23.4.2025

Payer: Árnason Faktor ehf.

Number: 13

Paid: 8.4.2025

Expires: 23.4.2026

Payer: Árnason Faktor ehf.

Upload documents